| 总计 | A组 | B组 | C组 | F/x2 | P |
年龄(岁,平均数 ± 标准差) | 63.73 ± 8.27 | 65.75 ± 6.58 | 61.43 ± 10.11 | 64.45 ± 7.29 | 0.939 | 0.401 |
性别(男/女) | 12/25 | 4/7 | 5/10 | 3/8 | 0.322 | 1.000* |
眼别(右眼/左眼) | 13/21 | 4/7 | 7/8 | 3/8 | 1.042 | 0.639* |
II期 | 9 (9/37) | 2 (2/11) | 4 (4/15) | 3 (3/11) | 5.607 | 0.233* |
III期 | 17 (17/37) | 4 (4/11) | 6 (6/15) | 7 (7/11) | ||
IV期 | 11 (14/37) | 5 (5/11) | 5 (5/16) | 1 (1/11) | ||
症状持续时间(个月) | 5.41 ± 2.41 | 6.21 ± 2.59 | 5.46 ± 2.41 | 4.46 ± 2.07 | 1.572 | 0.222 |
术前视力(LogMAR BCVA) | 0.83 ± 0.16 | 0.91 ± 0.15 | 0.78+0.19 | 0.80 ± 0.12 | 2.729 | 0.80 |
基底径(μm) | 829.08 ± 154.27 | 895.00 ± 143.00 | 803.86 ± 163.15 | 789.27 ± 143.97 | 1.174 | 0.195 |
最小径(μm) | 314.54 ± 100.15 | 362.17 ± 99.46 | 302.00 ± 100.98 | 278.55 ± 87.213 | 2.339 | 0.122 |
ELM基线缺损直径(μm) | 862.30 ± 195.83 | 905.92 ± 181.21 | 918.07 ± 203.78 | 743.73 ± 160.77 | 3.241 | 0.052 |
EZ基线缺损直径(μm) | 1047.70 ± 167.94 | 1100.25 ± 176.10 | 1067.21 ± 190.10 | 965.55 ± 95.78 | 2.123 | 0.135 |
IZ基线缺损直径(μm) | 1198.76 ± 247.30 | 1291.75 ± 219.96 | 1214.29 ± 291.71 | 1077.55 ± 171.56 | 2.364 | 0.109 |